# LOTEPREDNOL ETABONATE
> **ANDA213956** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-11-29
## Drug
- **FDA Application Number:** ANDA213956
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOTEPREDNOL ETABONATE
- **Generic name:** Loteprednol Etabonate
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** GEL
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** HIKMA
- **First approval:** 2023-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213956)
---
*MORVS · CC0 1.0*